World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
30395
World Ranking
14019
National Ranking
583

Overview

Vikas Gupta is affiliated with the Princess Margaret Cancer Centre in Canada. Their research primarily focuses on medical studies related to hematology and related subfields.

The scientist's main field of study is Medicine, with a specialized emphasis on Hematology, Genetics, Molecular Biology, Rheumatology, and Surgery. Their published work spans across multiple prominent medical topics, including:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Kruppel-like factors research
  • Multiple Myeloma Research and Treatments
  • Acute Lymphoblastic Leukemia research

Some of the recent notable papers authored or co-authored by them include:

  • "Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study," 2023, The Lancet
  • "ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial," 2020, Blood Advances
  • "Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts," 2020, British Journal of Haematology
  • "Survival following allogeneic transplant in patients with myelofibrosis," 2020, Blood Advances
  • "Critical illness in patients with hematologic malignancy: a population-based cohort study," 2021, Intensive Care Medicine

Vikas Gupta frequently collaborates with other researchers in their field. The most common co-authors include:

  • Ruben A. Mesa
  • Srđan Verstovšek
  • Hassan Sibai
  • Jean-Jacques Kiladjian
  • Dawn Maze

They have published across several key journals and platforms, notably:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Advances
  • HemaSphere
  • Journal of Clinical Oncology

Best Publications

  • A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

    Srdan Verstovsek;Ruben A. Mesa;Jason Gotlib;Richard S. Levy

  • Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

    Liran I. Shlush;Sasan Zandi;Amanda Mitchell;Weihsu Claire Chen

  • Epidemiology and Outcomes of Health-care–Associated Pneumonia: Results From a Large US Database of Culture-Positive Pneumonia

    Marin H. Kollef;Andrew Shorr;Ying P. Tabak;Vikas Gupta

  • A 17-gene stemness score for rapid determination of risk in acute leukaemia

    Stanley W. K. Ng;Amanda Mitchell;James A. Kennedy;James A. Kennedy;James A. Kennedy;Weihsu C. Chen

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome

    Brian L. McClune;Daniel J. Weisdorf;Tanya L. Pedersen;Gisela Tunes da Silva

  • Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure

    Michel Duval;John P. Klein;Wensheng He;Jean Yves Cahn

  • Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project.

    Diana M Merino;Lisa M McShane;David Fabrizio;Vincent Funari

  • The Nf2 Tumor Suppressor, Merlin, Functions in Rac-Dependent Signaling

    Reuben J. Shaw;J.Guillermo Paez;Marcello Curto;Ann Yaktine

  • Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.

    Andrew F. Shorr;Ying P. Tabak;Aaron D. Killian;Vikas Gupta

  • Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.

    Srdan Verstovsek;Ruben A Mesa;Jason R Gotlib;Vikas Gupta

  • OUTCOME OF TRANSPLANTATION FOR MYELOFIBROSIS

    Karen K. Ballen;Smriti Shrestha;Kathleen A. Sobocinski;Mei Jie Zhang

  • Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

    N. M. Kröger;J. H. Deeg;E. Olavarria;D. Niederwieser

  • Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial

    John Mascarenhas;Ronald Hoffman;Moshe Talpaz;Aaron T. Gerds

  • Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

    Joseph Pidala;Stephanie J. Lee;Kwang Woo Ahn;Stephen Spellman

  • Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: Results of a median 3-year follow-up of COMFORT-I

    Srdan Verstovsek;Ruben A. Mesa;Jason Gotlib;Richard S. Levy

  • Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

    Selina M. Luger;Olle Ringdén;Mei-Jie Zhang;Waleska S. Pérez

  • Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial.

    Claire N. Harrison;Alessandro M. Vannucchi;Uwe Platzbecker;Francisco Cervantes

  • Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses.

    Srdan Verstovsek;Jason Gotlib;Ruben A. Mesa;Alessandro M. Vannucchi

  • Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

    Liran I. Shlush;Sasan Zandi;Amanda Mitchell;Weihsu Claire Chen

Frequent Co-Authors

Mark D. Minden
Mark D. Minden Princess Margaret Cancer Centre
Aaron D. Schimmer
Aaron D. Schimmer Princess Margaret Cancer Centre
Srdan Verstovsek
Srdan Verstovsek The University of Texas MD Anderson Cancer Center
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Sagar Lonial
Sagar Lonial Emory University
Lawrence H. Boise
Lawrence H. Boise Emory University
Suzanne Kamel-Reid
Suzanne Kamel-Reid University Health Network
Jason Gotlib
Jason Gotlib Stanford University
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Wei Xu
Wei Xu Shenzhen University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t have to follow a single track. Many students explore alternative pathways and online degree options to broaden their opportunities in healthcare. For those seeking quicker entry into the workforce, fast lpn program options can fast-track your path to becoming a Licensed Practical Nurse, offering flexible schedules and faster completion times.

Mental health is a rapidly growing field, and online study options are making it more accessible than ever. If you’re interested in advanced practice, you may want to consider online psych np programs to become a Psychiatric Mental Health Nurse Practitioner. These programs blend flexibility and specialization, letting you build expertise in high-demand areas.

For students interested in the organizational side of healthcare, pursuing a Master’s in Healthcare Administration (MHA) opens up leadership and management roles. Affordable and accessible cheapest mha programs online provide a budget-friendly alternative to traditional campus options. You can also compare different cheapest mha programs online to find the best fit for your career goals and financial needs.

Best Scientists Citing Vikas Gupta

Trending Scientists

Recently Published Articles